ArticleOncology2024

Decision-Making at Swissmedic, the Swiss Regulatory Agency, with a Focus on (Neo)adjuvant Cancer Treatments.

Matea Zosso-Pavic et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.